CIK 1694620
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2021-Q2. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 56.13% | 6 |
| Unclassified | 14.74% | 4 |
| Technology Hardware & Equipment | 13.83% | 1 |
| Health Care Providers & Services | 10.75% | 1 |
| Health Care Equipment & Supplies | 4.55% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | PFE | PFIZER INC | Health Care | 15.61% |
| 2 | TMO | THERMO FISHER SCIENTIFIC INC. | Information Technology | 13.83% |
| 3 | TDOC | Teladoc Health, Inc. | Health Care | 10.75% |
| 4 | BMRN | BIOMARIN PHARMACEUTICAL INC | Health Care | 10.29% |
| 5 | JNJ | JOHNSON & JOHNSON | Health Care | 9.78% |
| 6 | FATE | FATE THERAPEUTICS INC | Health Care | 8.60% |
| 7 | HORIZON THERAPEUTICS PLC | Unclassified | 7.95% | |
| 8 | RCUS | Arcus Biosciences, Inc. | Health Care | 7.18% |
| 9 | ALLO | Allogene Therapeutics, Inc. | Health Care | 4.67% |
| 10 | MDT | Medtronic plc | Health Care | 4.55% |
9/13 names classified · sector 85.3% of weight · industry 85.3% · mkt cap 85.3%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 85.3% of the book is sector-classified (unclassified names shown, never dropped).
Classified: 54.1% of book weight (5/12 names) · unclassified 45.9%: TDOC, , FATE, RCUS, ALLO, PRQR, IMTX. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | PFEPFIZER INC | 30,000 | $1M | 15.6% | NEW |
| 2 | TMOTHERMO FISHER SCIENTIFIC INC | 2,000 | $1M | 13.8% | NEW |
| 3 | TDOCTELADOC HEALTH INC | 7,000 | $888,000 | 10.7% | NEW |
| 4 | BMRNBIOMARIN PHARMACEUTICAL INC | 11,000 | $850,000 | 10.3% | NEW |
| 5 | JNJJOHNSON & JOHNSON | 5,000 | $808,000 | 9.8% | NEW |
| 6 | FATEFATE THERAPEUTICS INC | 12,000 | $711,000 | 8.6% | ADD 20% |
| 7 | HORIZON THERAPEUTICS PLC | 6,000 | $657,000 | 8.0% | ADD 20% |
| 8 | RCUSARCUS BIOSCIENCES INC | 17,000 | $593,000 | 7.2% | TRIM −15% |
| 9 | ALLOALLOGENE THERAPEUTICS INC | 15,000 | $386,000 | 4.7% | NEW |
| 10 | MDTMEDTRONIC PLC | 3,000 | $376,000 | 4.6% | NEW |
| 11 | PRQRPROQR THRAPEUTICS N V | 40,000 | $335,000 | 4.1% | NEW |
| 12 | IMTXIMMATICS N.V | 10,000 | $130,000 | 1.6% | NEW |
| 13 | AMICUS THERAPEUTICS INC | 10,000 | $96,000 | 1.2% | NEW |
Where this firm's principals came from and which firms its alumni went on to found.
